SMN2 and proximal spinal muscular atrophy: The MLPA assay significantly improves SMA diagnosis by enabling simple and rapid detection of the main genetic defect of SMA, as well as evaluation of the SMN2 copy number, which is crucial for predicting disease severity and determining the extent of deletion in 5q13.2 [6].